Handelsbanken Fonder AB - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 207 filers reported holding CARDLYTICS INC in Q1 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of CARDLYTICS INC
ValueSharesWeighting
Q1 2022$330,000
-16.9%
6,0000.0%0.00%0.0%
Q4 2021$397,000
-15.5%
6,000
+7.1%
0.00%0.0%
Q3 2021$470,000
-33.9%
5,6000.0%0.00%
-50.0%
Q2 2021$711,000
+24.7%
5,600
+7.7%
0.00%
+33.3%
Q1 2021$570,000
-23.2%
5,2000.0%0.00%
-40.0%
Q4 2020$742,000
+102.2%
5,2000.0%0.01%
+66.7%
Q3 2020$367,0005,2000.00%
Other shareholders
CARDLYTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders